SUN-PO251: How the Nutritional Risk in Hospitalized Patients Determines the Customization Diet and Length of Stay: A Retrospective Study

2019 ◽  
Vol 38 ◽  
pp. S152
Author(s):  
C.A. Santos ◽  
A. Fonseca ◽  
A. Almeida ◽  
C. Lopes ◽  
F. Oliveira ◽  
...  
Author(s):  
Dilraj Dhillon ◽  
Thomas Randall ◽  
David Zezoff ◽  
Mouchumi Bhattacharyya

Background: Pyelonephritis is a urinary tract infection that ascends to involve the kidneys. It can also occur as an infection secondary to bacteremia. Some pathogens that commonly cause pyelonephritis are E. coli, enterobacteriaceae, staphylococci, and pseudomonas. The initial patient presentation usually involves fever, chills, nausea, vomiting, costovertebral angle tenderness, and flank pain. Other cystitis symptoms such as dysuria, increased urinary frequency, malodorous urine, and hematuria may or may not be present. Symptoms of pyelonephritis with bacteriuria are sufficient for the diagnosis of pyelonephritis. Aim: The aim of this study was to investigate a potential link between Type II Diabetes Mellitus and pyelonephritis. Methods: In this retrospective study, hospitalized patients during the study period were reviewed. Variables examined were sex, age, and length of stay. Patients were excluded if they had known urogenital abnormalities, indwelling catheters (Foley, nephrostomy, suprapubic, or who regularly perform clean intermittent catheterization), were pregnant, or were on dialysis. Results: Of 333 patients analyzed, diabetics had a longer length of stay then non-diabetics (4.49 vs 3.67 days respectively; p=0.0041) and females were significantly younger than men in hospitalized patients for pyelonephritis were (50.0 vs 63.5 years; p=<0.0001). Further, it was found that diabetics were significantly older than nondiabetics were (60.4 vs 47.3; p=<0.0001) and more diabetics getting admitted with pyelonephritis were men vs women (59.32% vs 35.27%; p=0.0007). Conclusion: Results of the study were significant in showing that of all pyelonephritis-hospitalized patients on average the length of stay was longer for diabetics and it demonstrated that female patients with pyelonephritis are significantly younger than male patients hospitalized with pyelonephritis. Of note, there was no significant difference in the length of stay for diabetic patients based on their treatment modality (diet controlled vs. oral medications vs. insulin dependent vs. combined). The study also showed that diabetics getting admitted for pyelonephritis are more men and older in age compared to the nondiabetics.


2020 ◽  
Vol 35 (1) ◽  
pp. 62-69
Author(s):  
Mariana Frigo de Moraes ◽  
Jaques Waisberg ◽  
Maria de Lourdes do Nascimento da Silva ◽  
Fernanda Cristina Alves de Lima ◽  
Diogo Oliveira Toledo

Objective: The purpose of this study was to analyze the presence of nutritional risk and their correlation with clinical outcome in elderly hospitalized patients. Methods: The study variables were weight, height, body mass index (BMI), nutritional risk, length of stay and death of hospitalized patients in a public hospital in São Paulo. These data were obtained by Sheet Nutritional Care, dietitians completed by the institution. Nutritional risk was determined by nutritional screening tool NRS-2002. To investigate the association between the presence of nutritional risk and other study variables, we used Rao & Scott test and multiple logistic regression (stepwise forward), with 5% significance level. It proceeded to univariate analysis, and variables with p <0.20, in ascending order of entry were included in multiple regression. They remained in the model the variables with p <0.05, or those set by at least 10% the value of odds ratio of other variables. Results: We evaluated the records of 2613 patients, with a mean age of 73.87 years, 54.84% female, 47.26% of the population were at nutritional risk and 37.3% undernutrition. The nutritional risk groups according to age showed that the greater the age, the prevalence greater risk for malnutrition. There was a good statistical correlation with BMI, because the risk was more prevalent in malnourished group (54.41%). It was found that 11.9% of those who had died nutritional risk, while those who did not risk, only 1.66%. Conclusion: From this study it was found that for older people studied the risk for malnutrition correlated positively with age, BMI, length of stay and the occurrence of deaths.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Ines Gragueb-Chatti ◽  
Alexandre Lopez ◽  
Dany Hamidi ◽  
Christophe Guervilly ◽  
Anderson Loundou ◽  
...  

Abstract Background Dexamethasone decreases mortality in patients with severe coronavirus disease 2019 (COVID-19) and has become the standard of care during the second wave of pandemic. Dexamethasone is an immunosuppressive treatment potentially increasing the risk of secondary hospital acquired infections in critically ill patients. We conducted an observational retrospective study in three French intensive care units (ICUs) comparing the first and second waves of pandemic to investigate the role of dexamethasone in the occurrence of ventilator-associated pneumonia (VAP) and blood stream infections (BSI). Patients admitted from March to November 2020 with a documented COVID-19 and requiring mechanical ventilation (MV) for ≥ 48 h were included. The main study outcomes were the incidence of VAP and BSI according to the use of dexamethasone. Secondary outcomes were the ventilator-free days (VFD) at day-28 and day-60, ICU and hospital length of stay and mortality. Results Among the 151 patients included, 84 received dexamethasone, all but one during the second wave. VAP occurred in 63% of patients treated with dexamethasone (DEXA+) and 57% in those not receiving dexamethasone (DEXA−) (p = 0.43). The cumulative incidence of VAP, considering death, duration of MV and late immunosuppression as competing factors was not different between groups (p = 0.59). A multivariate analysis did not identify dexamethasone as an independent risk factor for VAP occurrence. The occurrence of BSI was not different between groups (29 vs. 30%; p = 0.86). DEXA+ patients had more VFD at day-28 (9 (0–21) vs. 0 (0–11) days; p = 0.009) and a reduced ICU length of stay (20 (11–44) vs. 32 (17–46) days; p = 0.01). Mortality did not differ between groups. Conclusions In this cohort of COVID-19 patients requiring invasive MV, dexamethasone was not associated with an increased incidence of VAP or BSI. Dexamethasone might not explain the high rates of VAP and BSI observed in critically ill COVID-19 patients.


Sign in / Sign up

Export Citation Format

Share Document